fr

CARMAT receives FDA conditional approval to initiate the second cohort of the EFS study in the United States

CARMAT confirms the first successful heart transplant of a patient previously implanted with its total artificial heart

Download

CARMAT appoints Thierry Dupoux, previously Worldwide Vice President of Quality Assurance at LivaNova, as Senior Director of Quality Assurance

Download

CARMAT completes patient enrollment in the first part of the PIVOTAL study in line with the objective of obtaining CE marking in 2019

Download

CARMAT: Continuing progress in line with the objective of obtaining CE marking in 2019

Download

CARMAT advances the internationalization of the PIVOTAL study and obtains the approval to perform implants in Denmark

Download

2017 Annual Results

Download

2018 Financial Calendar

Download

CARMAT announces the success of its capital increase for an amount of €52.9 million after full exercise of the increase option

Download
Top of page